Revenue for the Twelve Months Ended December 31, 2024 Increased 31%
Net Income for the Twelve Months Ended December 31, 2024 Increased 206%
Cash Provided by Operations for the Twelve Months Ended December 31, 2024 Increased 600%
Previously Announced Share Repurchase Program for up to $1 Million Continues
As the federal government seeks to cut Medicaid expenses, the groundbreaking smart pill bottle technology can help by providing physicians, pharmacists and industry with improved medication adherence and prescription oversight and accountability.
Read MorePlatform designed to enhance new customer access, supply chain coordination, inventory management, and purchasing
MSO's can create their own catalog of Greenlane products, enhancing customer loyalty and ease of reordering
Read MoreRevenue increased 1% to $5.8M
Adjusted EBITDA increased $900,000 to $871,000 in Q4 2024
Cash flow from operations increased to $353,000 from $(236,000) in Q4 2023
Rebranded to ACCESS Newswire Inc, effective January 27, 2025
Compliance business was sold for $12.5M on February 28, 2025
Subscriptions increased to 1,124 from 1,053 in Q4 2023
The Company plans for its busiest exploration season to-date in 2025 targeting rare earth elements ("REE") and thorium ("Th") at its expansive land holdings in central Idaho
All three projects: Lemhi Pass, Mineral Hill, and Diamond Creek are included in the U.S.' National REE Inventory and located in Idaho's well-known and underexplored REE-Th Belt
IDR believes its projects are well suited for President Trump's recent Executive Order titled, "Immediate Measures to Increase American Mineral Production in the United States"
Read More
This investment harnesses artificial intelligence to deliver actionable insights for improving asset reliability, performance, and operational excellence across key process industries, including oil and gas, utilities, and cement.
Read More
Key Findings:
KOCH DLE Process achieves an average lithium recovery rate of 98%
Key brine contaminants average rejection greater than 99%, resulting in low purification production costs
Industry leading Lithium Chloride concentration attained
Li:TDS ratio of up to 0.129, averaging 0.126, significantly above the target Li:TDS of 0.08, expected to lower the cost with less evaporation during the EV battery grade purification process
43,500 gallons (165,000 litres) of high purity lithium chloride was produced that meet or exceeded the specifications required by downstream processors
The Shareholders Foundation, Inc. announced an update in the lawsuit that is pending for certain investors in The Toronto-Dominion Bank (NYSE: TD) shares. Investors who purchased shares of The Toronto-Dominion Bank on the NYSE should contact the Shareholders Foundation at [email protected] or call +1(858) 779 - 1554.
Read More
Soft tissue injuries like UCL tears, hamstring pulls and oblique strains are more common early in the season, but non-invasive treatment technology, sam®Recover can help athletes recover faster and stay on the field.
Read MoreThe Shareholders Foundation, Inc. announced that a deadline is coming up on May 05, 2025 in the lawsuit that was filed for certain investors in shares of Maravai LifeSciences Holdings, Inc. (NASDAQ: MRVI). Investors in shares of Maravai LifeSciences Holdings, Inc. (NASDAQ: MRVI) should contact the Shareholders Foundation at [email protected] or call +1(858) 779 - 1554.
Read More
XMPro today announced Version 1.4 of its Multi-Agent Generative System (MAGS). This update strengthens industrial AI teams' ability to make better decisions in dynamic environments
Read MoreMarathon Bancorp, Inc. (the "Company") (OTC Pink: MBBC), the holding company for Marathon Bank (the "Bank"), announced today that the Company has extended the community offering to allow additional time to sell shares of its common stock.
Read MoreThe Shareholders Foundation, Inc. announced that a deadline is coming up on April 7, 2025, in the lawsuit that was filed for certain investors in shares of Neumora Therapeutics, Inc. (NASDAQ: NMRA). Investors in shares of Neumora Therapeutics, Inc. (NASDAQ: NMRA) should contact the Shareholders Foundation at [email protected] or call +1(858) 779 - 1554.
Read More